BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schmocker RK, Wright MJ, Ding D, Javed AA, Cameron JL, Lafaro K, Burns WR, He J, Wolfgang CL, Burkhart RA. Duodenal, ampullary, and pancreatic neuroendocrine tumors: Oncologic outcomes are driven by tumor biology and tissue of origin. J Surg Oncol 2021;123:416-24. [PMID: 33125737 DOI: 10.1002/jso.26285] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ruff SM, DePeralta DK. ASO Author Reflections: Utilizing National Databases to Identify Areas of Future Focus When Studying Rare Tumors. Ann Surg Oncol 2021. [PMID: 34319476 DOI: 10.1245/s10434-021-10485-1] [Reference Citation Analysis]
2 Ruff SM, Standring O, Wu G, Levy A, Anantha S, Newman E, Karpeh MS Jr, Nealon W, Deutsch GB, Weiss MJ, DePeralta DK. Ampullary Neuroendocrine Tumors: Insight into a Rare Histology. Ann Surg Oncol 2021. [PMID: 34312800 DOI: 10.1245/s10434-021-10371-w] [Reference Citation Analysis]
3 Vanoli A, Grami O, Klersy C, Milanetto AC, Albarello L, Fassan M, Luchini C, Grillo F, Spaggiari P, Inzani F, Uccella S, Parente P, Nappo G, Mattiolo P, Milione M, Pietrabissa A, Cobianchi L, Schiavo Lena M, Partelli S, Di Sabatino A, Sempoux C, Capella C, Pasquali C, Doglioni C, Sessa F, Scarpa A, Rindi G, Paulli M, Zerbi A, Falconi M, Solcia E, La Rosa S. Ampullary Neuroendocrine Neoplasms: Identification of Prognostic Factors in a Multicentric Series of 119 Cases. Endocr Pathol 2022. [PMID: 35553369 DOI: 10.1007/s12022-022-09720-6] [Reference Citation Analysis]